Stock data
Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. (NAGE) reported revenue of US$129.42M and net income of US$17.38M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$129.42M | US$83.19M | US$16.28M | US$17.38M | — |
| 2024 | US$99.60M | US$61.59M | US$7.73M | US$8.55M | — |
| 2023 | US$83.57M | US$50.78M | -US$5.60M | -US$4.94M | — |
| 2022 | US$72.05M | US$42.80M | -US$18.63M | -US$16.54M | — |
| 2021 | US$67.45M | US$41.49M | -US$27.07M | -US$27.13M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$29.79M | US$0.96M | — |
| 2026-03-31 | US$31.47M | US$6.32M | — |
| 2025-12-31 | US$33.84M | US$4.13M | — |
| 2025-09-30 | US$33.99M | US$4.58M | — |
| 2025-06-30 | US$31.12M | US$3.61M | — |
| 2025-03-31 | US$30.48M | US$5.06M | — |
| 2024-12-31 | US$29.12M | US$7.18M | — |
| 2024-09-30 | US$25.58M | US$1.88M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.